Robert Eferl
- Cancer Research top 1%
- Oncology top 1%
- Cytokine Signaling Pathways and Interactions 13
- Bone health and treatments 7
- Cancer-related Molecular Pathways 4
- Immunology top 2%
- interferon and immune responses 6
- Hepatology top 2%
- Liver physiology and pathology 9
- Molecular Biology top 2%
- Bone Metabolism and Diseases 9
- CRISPR and Genetic Engineering 4
-
- Helicobacter pylori-related gastroenterology studies 5
- Co-authors
- Erwin F. WagnerLukas KennerRainer ZenzMartina RathHarald ScheuchRoméo RicciErwin TschachlerAstrid Hoebertz
- Cited by
- Cancer ResearchOncologyImmunology
In The Last Decade
Robert Eferl
68 papers receiving 6.6k citations
Hit Papers
Peers
Comparison fields: 5 of 134
- Cancer Research 1.3k
- Oncology 2.0k
- Immunology 1.4k
- Hepatology 453
- Molecular Biology 3.8k
Countries citing papers authored by Robert Eferl
This map shows the geographic impact of Robert Eferl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Eferl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Eferl more than expected).
Fields of papers citing papers by Robert Eferl
This network shows the impact of papers produced by Robert Eferl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Eferl. The network helps show where Robert Eferl may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robert Eferl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 11 | |
| 3 | 2022 | 19 | |
| 4 | 2021 | 9 | |
| 5 | 2018 | 130 | |
| 6 | 2017 | 105 | |
| 7 | 2015 | 17 | |
| 8 | 2014 | 80 | |
| 9 | 2014 | 10 | |
| 10 | 2011 | 59 | |
| 11 | 2011 | 21 | |
| 12 | 2010 | 66 | |
| 13 | 2010 | 6 | |
| 14 | 2009 | 46 | |
| 15 | 2008 | 151 | |
| 16 | 2007 | 25 | |
| 17 | 2006 | 187 | |
| 18 | Loss of Fra-2 expression leads to osteoporosis | 2003 | 1 |
| 19 | 2000 | 32 | |
| 20 | 1999 | 5 |
About Robert Eferl
Robert Eferl is a scholar working on Hepatology, Oncology and Immunology, having authored 68 papers that have together received 6.7k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (13 papers), Liver physiology and pathology (9 papers), Bone Metabolism and Diseases (9 papers), Bone health and treatments (7 papers), interferon and immune responses (6 papers), Helicobacter pylori-related gastroenterology studies (5 papers), CRISPR and Genetic Engineering (4 papers) and Cancer-related Molecular Pathways (4 papers). The work is most often cited by research in Cancer Research (1.3k citations), Oncology (2.0k citations) and Immunology (1.4k citations). Robert Eferl has collaborated with scholars based in Austria, Germany and Spain. Frequent co-authors include Erwin F. Wagner, Lukas Kenner, Rainer Zenz, Martina Rath, Harald Scheuch, Roméo Ricci, Erwin Tschachler, Astrid Hoebertz, Peter Angel and Maria Sibilia. Their work appears in journals such as Hepatology, The Journal of Cell Biology, Scientific Reports, Nature and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.